Graham Parry analyst BAML

Currently out of the existing stock ratings of Graham Parry, 3 are a HOLD (42.86%), 1 are a SELL (14.29%), 3 are a BUY (42.86%).

Graham Parry

Work Performance Price Targets & Ratings Chart

Analyst Graham Parry works at BAML with a stock forecast success ratio of 16.67% fulfilled within 1722 days on average.

Graham Parry’s has documented 12 price targets and ratings displayed on 2 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on NVS, Novartis AG ADR at 12-Sep-2023.

Wall Street Analyst Graham Parry

Analyst best performing recommendations are on GSK (GLAXOSMITHKLINE PLC ADR).

Average potential price target upside

GSK GlaxoSmithKline PLC ADR NVS Novartis AG ADR

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

44

$-0.98 (-2.18%)

18.72

3 months 25 days ago

1/14 (7.14%)

$5.1 (13.11%)

105

Buy

48

$3.02 (6.71%)

39

4 months 15 days ago

1/3 (33.33%)

$9.46 (24.55%)

265

Hold

19.52

$-25.46 (-56.60%)

18.9

9 months 4 days ago

0/3 (0%)

$-14.87 (-43.24%)

Hold

19.58

$-22.45 (-53.41%)

19.96

1 years 28 days ago

0/2 (0%)

$-16.05 (-45.05%)

Buy

21.66

1 years 2 months 1 days ago

0/13 (0%)

$-19.7 (-47.63%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Graham Parry?

On 2014

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?